Call us: (+856-21) 314930Â |Â Â
About PDC3
PDC3 is a state-owned pharmaceutical enterprise specializing in pharmaceutical research, development, and production. We focus on medicines for treating anemia, vitamins, antipyretics, analgesics, and cough medications.
Since our establishment in 1987, we have been committed to producing high-quality pharmaceutical products that meet international standards. Our dedication to research and development has positioned us as a leader in the pharmaceutical industry.
We continuously strive to improve our manufacturing processes and implement stringent quality control measures. Our facility operates in accordance with ISO standards and Good Manufacturing Practice (GMP) guidelines, ensuring the safety and efficacy of our products.
Mission & Vision
Our Mission
Medical Innovation Inspired By Lao Ideas and creatively presented to the world.
🎯
Our Vision
Corporate motto are the principles that guide behavior within our company
ðŸ”
Corporate Motto: Principles That Guide Our Behavior
01
Professionalism
02
Total Quality
03
Innovation
04
Unity
Leadership Team
Dr. Lahounh CHANTHABOUT
Managing Director
Dr. Phoukhong Chommala
Deputy Managing Director
Mr. Khamphouy INTHAVONG
Vice Managing Director
Dr. Manivone SISAVENGSOUK
Vice Managing Director
PDC3 ORGANIZATIONAL CHART
Certifications & Quality Standards
We continuously implement stringent quality control measures and maintain international certifications to ensure the safety and efficacy of our products.
Our Journey
1987
PDC3 was established as a government pharmaceutical research and production facility.
1983
Partnership with Macao Iakala for technical cooperation and production expansion.
1987-1990
Installation and commissioning of modern pharmaceutical production equipment.
2000
Expanded production capacity with investment exceeding 100 million kip.
2006
Obtained ISO certification and implemented QA/QC systems.
2011-2015
Achieved GMP certification and expanded product portfolio.
2018
2018-2020
Partnership with TSUJIKO Co Ltd for technology transfer and quality enhancement.
2021
Research and development of new drug formulas.
- Nono-Plas-B12 / 10ml
- Magnesium Sulfate 50% / 10ml
- Sodium Chloride 20% / 10ml
- Mosquito Repellent Cream
- Mosquito Spray
2022
Research and development of new drug formulas.
- Gel for Star Song
- Falovirr Dry Sp 66.7mg / 5ml
- Toilet Cleaner
- Floor Cleaner
- Dishwasher
2023
Research and development of new drug formulas.
- Magnesium Sulfate 15% / 10ml
- Potassium Chloride 100mg / 10ml
- Tramadol Hydrochloride 100mg / 2ml
- Furosix 20mg / 2ml
- Vitamin C 500mg / 2ml
- Keakhaiwad Syrup
- Azithromycin Dry Syrup 200mg
2024
Research and development of new drug formulas.
- Sodium Chloride 20% / 2ml
- Magnesium Sulfate 50% / 10ml
- Magnesium Sulfate 15% / 10ml
- Potassium Chloride 10% / 10ml
- Tra-King 100mg / 2ml
- Tra-King 100mg Tablet
- Tra-King 50mg Tablet
- LM-500 (Paracetamol 500mg / Tablet)
- Bromhexine 8mg
- Metronidazole 500mg
2024 (continued)
Research and development of new drug formulas.
- Furosemide 20mg / 2ml
- Semaglutide 3mg, 7mg, 14mg
- Ketoprofen
- Hemodialysis A & B
- Ketoprofen 100mg / 2ml
- VA.HEEZ Cream 50mcg
- Tire Zeptid 10mg, 20mg, 30mg
Company Statistics
Production Capacity
Certifications & Quality Standards
1983
Technical cooperation agreement with JICA and Macao Iakala for pharmaceutical production
1987
Establishment of pharmaceutical research and production facility
1988
Installation of modern production equipment and quality control systems
2000
Major facility expansion with 100 million kip investment in modern equipment
2001
Implementation of advanced pharmaceutical production technologies
2006
Achieved ISO certification and QA/QC standards including Kaldect Tea, Dechlosal Tea, and Aromatic products
2011-2015
Obtained GMP certification for pharmaceutical production facilities
2018
Technology partnership with TSUJIKO Co Ltd for quality enhancement and product development
Strategic Partnerships
2018
Partnership agreement with Tsujiko Co., Ltd (Japan) and Consulus Pte Co. Ltd (Singapore) for technical cooperation and business development
2010-2015
Collaboration with KBN (Sino-American Kunming Baker Norton Pharmaceutical Co.) for production and distribution
1995-2004
Partnership with Labiofam SA for production of medicines, including pharmaceutical research and development of traditional and modern medicines
Research & Development
Our Research and Development department is dedicated to innovation in pharmaceutical sciences. We focus on both traditional medicine research and modern pharmaceutical development, ensuring our products meet the highest standards of efficacy and safety.
Our R&D team conducts extensive research on medicinal plants and herbs, analyzing their therapeutic properties and developing new formulations. We have successfully developed over 10 types of medicines derived from natural sources, combining traditional knowledge with modern scientific methods.
Medicinal Plant Research
Awards & Achievements
PDC3 is proud to be recognised for our commitment to quality, innovation, and pharmaceutical excellence in Laos and beyond.
